Values First Advisors, Inc. Praxis Precision Medicines, Inc. Transaction History

Values First Advisors, Inc.

  • $182 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022
SELL
$1.75 - $11.34 $80,482 - $521,526
-45,990 Closed
0 $0
Q1 2022

May 03, 2022
BUY
$10.21 - $20.29 $106,377 - $211,401
10,419 Added 29.29%
45,990 $470,000
Q4 2021

Mar 10, 2022
BUY
$16.76 - $22.99 $596,169 - $817,777
35,571 New
35,571 $701,000
Q3 2021

Nov 15, 2022
BUY
$13.15 - $22.56 $348,172 - $597,321
26,477 New
26,477 $490,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.55B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email